Back to search
FDAFDA · Food and drugs·Recall number D-104-2013

Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR

Published January 2, 2013 · Recall initiated: October 29, 2012

Summary

FDA records drug Class II recall D-104-2013, published January 2, 2013 and initiated October 29, 2012. Recalling firm: Alara Pharmaceutical Co; Status: Terminated; Reported quantity: 7,432 bottles; Lot: 11T7011A, Exp. Date: 12/2012. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent; 15 month stability

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Alara Pharmaceutical Co
Distributor
Nationwide
Lot
11T7011A, Exp. Date: 12/2012
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR recalled?

Yes. FDA published recall D-104-2013 on January 2, 2013. Reported hazard: Subpotent; 15 month stability

What should I do if I have this product?

Voluntary: Firm initiated · Letter